AI Engines For more Details: Perplexity Kagi Labs You
Cancer Prevention: Cruciferous vegetables contain phytochemicals such as glucosinolates, which are broken down into bioactive compounds like indoles, isothiocyanates, and sulforaphane. These compounds have been shown to possess anti-cancer properties by inhibiting the growth of cancer cells, promoting apoptosis (cell death) in cancer cells, and reducing inflammation. Regular consumption of cruciferous vegetables may help lower the risk of various types of cancer, including breast, prostate, lung, colorectal, and bladder cancer.
Heart Health: Cruciferous vegetables are rich in fiber, vitamins, minerals, and antioxidants, all of which contribute to heart health. The fiber helps lower cholesterol levels and improve blood lipid profiles, reducing the risk of cardiovascular diseases such as heart attack and stroke. Antioxidants like vitamin C and beta-carotene help prevent oxidative stress and inflammation in the cardiovascular system, promoting healthy blood vessels and reducing the risk of atherosclerosis.
Bone Health: Cruciferous vegetables contain nutrients like calcium, magnesium, phosphorus, and vitamin K, all of which are essential for maintaining strong and healthy bones. Vitamin K, in particular, plays a crucial role in bone metabolism and helps prevent osteoporosis and fractures. Consuming cruciferous vegetables as part of a balanced diet can contribute to overall bone health and reduce the risk of bone-related disorders.
Digestive Health: The fiber content in cruciferous vegetables supports digestive health by promoting regular bowel movements, preventing constipation, and nourishing beneficial gut bacteria. These vegetables also contain compounds that may help protect against digestive disorders such as inflammatory bowel disease (IBD), diverticulosis, and colorectal cancer.
Anti-Inflammatory Properties: Cruciferous vegetables contain various phytochemicals with anti-inflammatory properties, which help reduce inflammation throughout the body. Chronic inflammation is linked to the development of various diseases, including cardiovascular diseases, diabetes, and autoimmune disorders. Including cruciferous vegetables in the diet may help lower systemic inflammation and reduce the risk of chronic inflammatory conditions.
Blood Sugar Control: Cruciferous vegetables have a low glycemic index (GI), meaning they cause a gradual and steady increase in blood sugar levels after consumption. This makes them suitable for individuals with diabetes or those looking to manage blood sugar levels. The fiber and antioxidants in cruciferous vegetables also contribute to improved insulin sensitivity and glucose metabolism.
Weight Management: Cruciferous vegetables are low in calories but high in fiber, making them an excellent choice for individuals looking to manage their weight. The fiber content promotes feelings of fullness and satiety, reducing overall calorie intake and supporting weight loss or weight maintenance efforts.
Detoxification: Some compounds found in cruciferous vegetables, such as sulforaphane, have been shown to support the body's natural detoxification processes by enhancing the activity of detoxification enzymes in the liver. This may help eliminate harmful toxins and carcinogens from the body and reduce the risk of toxin-related diseases.
Rank | Probiotic | Impact |
---|---|---|
species | Anaerobutyricum hallii | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.3 | -0.3 | |
Acne | 0.6 | 0.5 | 0.2 |
ADHD | 1.5 | 2.6 | -0.73 |
Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.2 | 1.5 |
Allergic Rhinitis (Hay Fever) | 0.2 | 0.6 | -2 |
Allergies | 3.5 | 1.7 | 1.06 |
Allergy to milk products | 0.6 | 1.4 | -1.33 |
Alopecia (Hair Loss) | 0.5 | 0.8 | -0.6 |
Alzheimer's disease | 3.6 | 3.1 | 0.16 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.9 | 0.5 | 0.8 |
Ankylosing spondylitis | 0.9 | 1.3 | -0.44 |
Anorexia Nervosa | 1.2 | 0.9 | 0.33 |
Antiphospholipid syndrome (APS) | 0.3 | 0.6 | -1 |
Asthma | 1.5 | 1.1 | 0.36 |
Atherosclerosis | 1.3 | 0.5 | 1.6 |
Atrial fibrillation | 1.4 | 3.5 | -1.5 |
Autism | 6.4 | 5.2 | 0.23 |
Barrett esophagus cancer | 1.3 | -1.3 | |
Bipolar Disorder | 1.2 | 2.6 | -1.17 |
Brain Trauma | 1.8 | 0.5 | 2.6 |
Breast Cancer | 0.3 | 0.2 | 0.5 |
Carcinoma | 1.4 | 2.9 | -1.07 |
Celiac Disease | 1.8 | 0.9 | 1 |
Cerebral Palsy | 0.3 | 0.3 | 0 |
Chronic Fatigue Syndrome | 2.7 | 3.8 | -0.41 |
Chronic Kidney Disease | 1.6 | 0.6 | 1.67 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.9 | 0.3 | 2 |
Chronic Urticaria (Hives) | 0.9 | 0.9 | |
Coagulation / Micro clot triggering bacteria | 0.9 | 0.2 | 3.5 |
Colorectal Cancer | 1.9 | 4.4 | -1.32 |
Constipation | 0.6 | 0.5 | 0.2 |
Coronary artery disease | 2 | 1.6 | 0.25 |
COVID-19 | 8.4 | 3.3 | 1.55 |
Crohn's Disease | 5.9 | 4.6 | 0.28 |
cystic fibrosis | 0.3 | 0.3 | 0 |
deep vein thrombosis | 0.6 | 0.2 | 2 |
Depression | 6.4 | 8 | -0.25 |
Dermatomyositis | 0.3 | -0.3 | |
Eczema | 0.6 | 1.5 | -1.5 |
Endometriosis | 0.3 | 1.5 | -4 |
Eosinophilic Esophagitis | 0.3 | 0.3 | |
Epilepsy | 0.8 | 2.6 | -2.25 |
erectile dysfunction | 0.5 | -0.5 | |
Fibromyalgia | 1.5 | 1.4 | 0.07 |
Functional constipation / chronic idiopathic constipation | 1.5 | 2 | -0.33 |
gallstone disease (gsd) | 1.5 | 1.5 | |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | 0.6 | 0 |
Generalized anxiety disorder | 0.3 | 0.5 | -0.67 |
giant cell arteritis | 0.3 | -0.3 | |
Glioblastoma | 1.2 | 0.6 | 1 |
Gout | 1.4 | 0.3 | 3.67 |
Graves' disease | 2.1 | 1.4 | 0.5 |
Halitosis | 0.2 | 0.9 | -3.5 |
Hashimoto's thyroiditis | 1.5 | 2.3 | -0.53 |
Hemorrhoidal disease, Hemorrhoids, Piles | 0.6 | 0.8 | -0.33 |
Hidradenitis Suppurativa | 0.2 | 0.3 | -0.5 |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.3 | 1.6 | -4.33 |
hypercholesterolemia (High Cholesterol) | 0.8 | 1.4 | -0.75 |
hyperglycemia | 0.6 | 1.4 | -1.33 |
Hyperlipidemia (High Blood Fats) | 1.3 | 0.2 | 5.5 |
hypersomnia | 0.6 | 0.6 | 0 |
hypertension (High Blood Pressure | 4 | 1.2 | 2.33 |
Hypothyroidism | 1.4 | 1.4 | |
Hypoxia | 0.6 | -0.6 | |
IgA nephropathy (IgAN) | 2.5 | 1.1 | 1.27 |
Inflammatory Bowel Disease | 6 | 2.3 | 1.61 |
Insomnia | 0.3 | 0.6 | -1 |
Intelligence | 1.2 | 0.5 | 1.4 |
Intracranial aneurysms | 1.1 | 0.3 | 2.67 |
Irritable Bowel Syndrome | 4 | 2.9 | 0.38 |
Liver Cirrhosis | 3.1 | 4 | -0.29 |
Long COVID | 10.3 | 6 | 0.72 |
Low bone mineral density | 1.9 | 0.2 | 8.5 |
Lung Cancer | 2 | 2 | |
ME/CFS with IBS | 1.8 | 0.9 | 1 |
ME/CFS without IBS | 0.3 | 1.7 | -4.67 |
Metabolic Syndrome | 5.6 | 6.2 | -0.11 |
Mood Disorders | 7.7 | 10.7 | -0.39 |
multiple chemical sensitivity [MCS] | 0.6 | 0.5 | 0.2 |
Multiple Sclerosis | 2 | 2.1 | -0.05 |
Multiple system atrophy (MSA) | 0.6 | 0.8 | -0.33 |
myasthenia gravis | 0.3 | -0.3 | |
Neuropathy (all types) | 1.2 | -1.2 | |
neuropsychiatric disorders (PANDAS, PANS) | 0.6 | 1.1 | -0.83 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.5 | 0.8 | 3.38 |
Obesity | 4.8 | 4.9 | -0.02 |
obsessive-compulsive disorder | 1.7 | 2.5 | -0.47 |
Osteoarthritis | 0.9 | 0.5 | 0.8 |
Osteoporosis | 1.2 | 1.4 | -0.17 |
pancreatic cancer | 0.2 | 0.2 | |
Parkinson's Disease | 2.7 | 4 | -0.48 |
Polycystic ovary syndrome | 2.2 | 0.9 | 1.44 |
Postural orthostatic tachycardia syndrome | 0.3 | -0.3 | |
Premenstrual dysphoric disorder | 0.2 | -0.2 | |
primary biliary cholangitis | 0.8 | 0.8 | 0 |
Psoriasis | 0.7 | 1.2 | -0.71 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 5 | 4 | 0.25 |
Rosacea | 0.2 | 0.2 | |
Schizophrenia | 1.7 | 4.9 | -1.88 |
scoliosis | 0.5 | 0.5 | 0 |
sensorineural hearing loss | 0.3 | 1.2 | -3 |
Sjögren syndrome | 2.1 | 1.5 | 0.4 |
Sleep Apnea | 2.9 | 2.9 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.1 | -1.1 | |
Stress / posttraumatic stress disorder | 3.1 | 1.1 | 1.82 |
Systemic Lupus Erythematosus | 1.5 | 2.4 | -0.6 |
Tic Disorder | 0.2 | 0.3 | -0.5 |
Type 1 Diabetes | 1.7 | 0.6 | 1.83 |
Type 2 Diabetes | 3.7 | 5.3 | -0.43 |
Ulcerative colitis | 3.4 | 1.2 | 1.83 |
Unhealthy Ageing | 1.5 | 1.2 | 0.25 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.